NewsBenzinga艾伯维向 FDA 提交 etentamig 的 BLA 申请;这是一种第二代 BCMA×CD3 双特异性抗体 T 细胞连接器,采用静脉给药,用于治疗复发性或难治性多发性骨髓瘤成人患者 艾伯维向 FDA 提交 etentamig 的 BLA 申请;这是一种第二代 BCMA×CD3 双特异性抗体 T 细胞连接器,采用静脉给药,用于治疗复发性或难治性多发性骨髓瘤成人患者 Benzinga 2026.10.27 12:13 (GMT+0) Open on Benzinga Other news Jensen Huang Offers Nvidia Return If Board Wants Him Back Nvidia Tracks Seventh Weekly Loss Ahead of Earnings ‘You Don’t Want Rogue Agents’: Jamie Dimon Shuts Meta’s Muse AI Agent Out of JPMorgan. What It Means for META Stock. Investors Press for Answers From Nvidia, Where ‘Everything Has Changed’ Jensen Huang Signals Return to Nvidia CEO Role: Says Outpouring of Outside Support Is 'Stunning' Do Wall Street Analysts Like Diamondback Energy Stock?
‘You Don’t Want Rogue Agents’: Jamie Dimon Shuts Meta’s Muse AI Agent Out of JPMorgan. What It Means for META Stock.